Eli Lilly and Co (LLY)
778.20
+41.00
(+5.56%)
USD |
NYSE |
Apr 30, 13:35
Eli Lilly Cash from Operations (Quarterly): -311.90M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -311.90M |
| September 30, 2023 | 2.190B |
| June 30, 2023 | 631.90M |
| March 31, 2023 | 1.731B |
| December 31, 2022 | 1.663B |
| September 30, 2022 | 2.217B |
| June 30, 2022 | 1.183B |
| March 31, 2022 | 2.523B |
| December 31, 2021 | 2.262B |
| September 30, 2021 | 1.631B |
| June 30, 2021 | 1.776B |
| March 31, 2021 | 1.697B |
| December 31, 2020 | 1.815B |
| September 30, 2020 | 1.807B |
| June 30, 2020 | 2.495B |
| March 31, 2020 | 382.40M |
| December 31, 2019 | 1.964B |
| September 30, 2019 | 1.510B |
| June 30, 2019 | 1.052B |
| March 31, 2019 | 311.30M |
| December 31, 2018 | 1.449B |
| September 30, 2018 | 2.122B |
| June 30, 2018 | 1.518B |
| March 31, 2018 | 436.50M |
| December 31, 2017 | 1.744B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.881B |
| June 30, 2017 | 1.651B |
| March 31, 2017 | 339.90M |
| December 31, 2016 | 2.006B |
| September 30, 2016 | 1.662B |
| June 30, 2016 | 1.402B |
| March 31, 2016 | -219.10M |
| December 31, 2015 | 996.10M |
| September 30, 2015 | 1.105B |
| June 30, 2015 | 948.60M |
| March 31, 2015 | -84.80M |
| December 31, 2014 | 1.441B |
| September 30, 2014 | 1.691B |
| June 30, 2014 | 1.054B |
| March 31, 2014 | 272.30M |
| December 31, 2013 | 1.727B |
| September 30, 2013 | 1.992B |
| June 30, 2013 | 1.637B |
| March 31, 2013 | 379.40M |
| December 31, 2012 | 1.602B |
| September 30, 2012 | 1.544B |
| June 30, 2012 | 1.306B |
| March 31, 2012 | 852.50M |
| December 31, 2011 | 1.945B |
| September 30, 2011 | 2.073B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-311.90M
Minimum
Dec 2023
2.523B
Maximum
Mar 2022
1.590B
Average
1.731B
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 538.00M |
| Madrigal Pharmaceuticals Inc | -79.93M |
| Vertex Pharmaceuticals Inc | 234.60M |
| Viking Therapeutics Inc | -6.134M |
| Moderna Inc | 622.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.924B |
| Cash from Financing (Quarterly) | 3.545B |
| Free Cash Flow | -3.152B |
| Free Cash Flow Per Share (Quarterly) | -2.172 |
| Free Cash Flow to Equity (Quarterly) | -7.02B |
| Free Cash Flow to Firm (Quarterly) | -1.881B |
| Free Cash Flow Yield | -0.45% |